NEW YORK (TheStreet) -- CHANGE IN RATINGS
downgraded at Credit Suisse to Neutral from Outperform on lack of near term catalysts and expecting revenue to decline next 4 quarters. Price target dropped from $39 to $32.50.
downgraded at ThinkEquity from Buy to Hold. $30 price target. Weaker demand could extend into the new year.
downgraded at UBS from Buy to Neutral. $30 price target. Earnings momentum has slowed down, which could cut into the company's multiple.
downgraded at Baird from Outperform to Neutral. $36 price target. Company gave disappointing guidance and the stock lacks near-term catalysts.
rated new Positive at Susquehanna. $53 price target. Company should continue to expand its global presence and could exceed consensus expectations.
upgraded at Soleil from Hold to Buy. $56 price target. Company should benefit from a competitor's supply disruption.
rated new Outperform at JMP Securities. $72 price target. Company has better visibility than its peers.
upgraded at Deutsche from Hold to Buy. $75 price target. Company should benefit from secular growth drivers around Chinese TV demand and Windows 7.
upgraded at BMO to Outperform. $90 price target. Company likely to restructure its business and announce a buyback plan.
rated new Buy at Sterne Agee. $105 price target. Margins and grow along with higher volumes.
rated new Buy at UBS. $60 price target. Company is leveraged to a recovery in the luxury travel segment.
rated new Buy at UBS. $42 price target. High franchise rats cut capital investment requirements.
downgraded at Morgan Keegan from Market Perform to Underperform. $7.80 price target. Estimates also cut, given lower Devices/Services expectations.
downgraded at Goldman from Buy to Neutral. Stock also taken off the Conviction List, as the company will see some blockbuster drugs soon go generic.
rated new Hold at Jefferies. $15 price target. Legacy print assets could weigh on growth.
downgraded at Baird from Outperform to Neutral. $41 price target. New product sales may not ramp up until the second half of 2011.
downgraded at Susquehanna from Positive to Neutral. Valuation call, as the stock is up nearly 50% from its lows.
rated new Buy at Jefferies. $42 price target. Digital strategy should help boost future margins.
rated new Buy at Sterne Agee. $100 price target. Margins should expand, along with improving global commerce.
upgraded at Oppenheimer from Perform to Outperform. $70 price target. Company should continue to generate solid growth into 2011.
STOCK COMMENTS / EPS CHANGES
numbers upped at Goldman through 2012. Company is seeing better commercial air freight. Neutral rating and new $55 price target.
estimates upped at Citigroup through 2011. Company is seeing better enterprise demand and Acrobat sales. Buy rating and $42 price target.
estimates, target lowered at Citigroup. Shares of AMR now seen reaching $8. Estimates also reduced, to match the company's new guidance. Hold rating.
price target cut at Barclays. APC price target trimmed to $66 from $68. Focusing on its international deep-water drilling program. Maintain Overweight rating.
price target raised at Barclays to $230 from $225 on strong 4Q10 results. Business is firing on all cylinder. Maintain Equal Weight rating.
estimates, target raised at Goldman. Shares of AZO now seen reaching $224. Estimates also increased, given better sales growth and increased buyback activity. Sell rating.
price target cut at Citi. CAG price target trimmed by a dollar to $29 on weak 1Q11 results. Maintain Buy due to valuation and second half catalysts.
target lowered at Morgan Stanley to $22. Company is seeing lower growth and facing increased competition. Equal-weight rating.
estimates, target boosted at Goldman. Shares of CAT now seen reaching $77. Estimates also upped, following positive channel checks. Neutral rating.
price target higher at Credit Suisse to $42 from $38 as 3Q10 results showed better fuel, currency and cost performance. Maintain Neutral rating.
estimates increased at Citigroup through 2011. Bookings already looking strong for the new year. Buy rating and $47 price target.
( CEG) numbers boosted at UBS. Shares of CEG now seen reaching $33. Estimates also upped, given higher expectations for NewEnergy. Neutral rating.
estimates, target boosted at Citigroup. Shares of CTAS now seen reaching $27.50. Estimates also upped, given the company's stock repurchase program.
price target lower at Barclays. DVN price target cut to $73 from $77. As strategic repositioning is almost complete, DVN appears ready to focus exclusively on it onshore North American assets. Reiterate Overweight rating.
price target trimmed at Barclays to $83 from $86. Expecting strong margin expansion. Maintain Overweight rating.
price target lower at Barclays to $92 from $96. Relative cheapness could be related to recent corporate governance changes, Barclays said. Reiterate Overweight rating.
numbers reduced at Goldman. Shares of PMCS now seen reaching $10. Estimates also cut, to match the company's new sales guidance. Neutral rating.
numbers boosted at Piper. Shares of PVH now seen reaching $65. Estimates also upped, as the company can gain market share in Europe and Asia.
estimates cut at Morgan Stanley through 2012. Company reduced guidance and interest rates should remain low. Equal-weight rating and $15 price target.
estimates, target increased at Goldman . SWI estimates were raised through 2012, Goldman Sachs said. Latest checks suggest a more constructive market environment. Neutral rating and new $20 price target.
estimates, target raised at Sterne Agee. Shares of SWKS now seen reaching $22, according to Sterne Agee. Estimates also increased, to match the company's new guidance. Buy rating.
target raised at Morgan Stanley to $24. Company boosted guidance, given better demand across the board. Overweight rating.
target, estimates boosted at Barclays to $32 from $30, following recent industry checks. 2010 and 2011 EPS estimates lifted to $3.08 and $3.60, respectively. Maintain Overweight rating.
estimates, target cut at Goldman. Estimates were reduced through 2012. Company is cutting Cessna production. Buy rating and new $24 price target.
This article was written by a staff member of TheStreet.